Apella Capital, LLC NERV β€” MINERVA NEUROSCIENCES INC

Ownership history in Apella Capital, LLC  Β·  6 quarters on record

AI Ownership Summary

Apella Capital, LLC reported MINERVA NEUROSCIENCES INC (NERV) in 6 quarterly 13F filings from 2025 Q1 through 2026 Q2. The latest visible filing shows NERV at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this NERV ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Apella Capital, LLC's position in MINERVA NEUROSCIENCES INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

NERV was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

NERV stock page Apella Capital, LLC fund profile Apella Capital, LLC full holdings
How Apella Capital, LLC held NERV β€” position size vs. price
% of Fund (quarterly)    NERV price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED β€” β€” β€” 42,250 β€” 0% 0.00% $202K 2026-07-08 $4.62
2026 Q1 REDUCED β€” β€” β€” 42,250 -130 -0.3% 0.00% $284K 2026-04-20 $6.89
2025 Q4 ADDED β€” β€” β€” 42,380 +3,066 +7.8% 0.00% $170K 2026-01-21 $4.19
2025 Q3 ADDED β€” β€” β€” 39,314 +18,375 +87.8% 0.00% $99K 2025-10-17 $2.49
2025 Q2 ADDED β€” β€” β€” 20,939 +314 +1.5% 0.00% $34K 2025-07-08 $1.63
2025 Q1 INITIATED β€” β€” β€” 20,625 β€” β€” 0.00% $28K 2025-04-10 $1.35

FAQ About Apella Capital, LLC and NERV

These are the practical questions this page is built to answer before you even open the full history table.

How long has Apella Capital, LLC reported owning NERV?

Apella Capital, LLC reported NERV across 6 quarterly 13F filings, from 2025 Q1 through 2026 Q2.

What was the largest reported NERV position in Apella Capital, LLC's portfolio?

The largest reported portfolio weight for NERV was 0.00% in 2026 Q1.

What is the latest reported NERV position on this page?

The most recent filing on this page is 2026 Q2, when Apella Capital, LLC reported 42,250 shares, equal to 0.00% of portfolio, with an estimated market value of $202K.

What does the chart on this NERV ownership page compare?

The chart compares Apella Capital, LLC's quarterly NERV portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Apella Capital, LLC time their NERV position?

Based on 13F filing dates vs. subsequent NERV price moves, Apella Capital, LLC correctly timed 5 out of 5 reported position changes (100%). The annualised alpha on NERV relative to SPY over the holding period was +1990.0%.

← Back to Apella Capital, LLC Holdings